Cargando…
2022. Modeling Improved Patient Management and Hospital Savings with SeptiCyte LAB in the Diagnosis of Sepsis at ICU Admission
BACKGROUND: The ability to accurately diagnose sepsis at ICU admission is key to effective clinical management, patient safety, and efficient hospital resource utilization. Most tests used for sepsis diagnosis, including pathogen detection and host-based biomarker approaches, are lacking in either s...
Autor principal: | Mchugh, Leo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252755/ http://dx.doi.org/10.1093/ofid/ofy210.1678 |
Ejemplares similares
-
Erratum: Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU
Publicado: (2020) -
Evaluation of the host immune response assay SeptiCyte RAPID for potential triage of COVID-19 patients
por: Montero, Maria Milagro, et al.
Publicado: (2023) -
Stratification of COVID-19 Severity Using SeptiCyte RAPID, a Novel Host Immune Response Test
por: Gravrand, Victor, et al.
Publicado: (2023) -
SeptiFast for diagnosis of sepsis in severely ill patients from a Brazilian hospital
por: Sitnik, Roberta, et al.
Publicado: (2014) -
LightCycler SeptiFast in early diagnosis of sepsis: our experience
por: Raineri, SM, et al.
Publicado: (2009)